Literature DB >> 20484173

Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial.

Gerd Bobe1, Paul S Albert, Leah B Sansbury, Elaine Lanza, Arthur Schatzkin, Nancy H Colburn, Amanda J Cross.   

Abstract

Serum interleukin-6 (IL-6), a proinflammatory cytokine, is considered an indicator of inflammation and may be an indicator of colorectal carcinogenesis given that inflammation can promote carcinogenesis. Flavonols, which can be found in fruits and vegetables, may inhibit colorectal carcinogenesis partly by inhibiting inflammation. We estimated odds ratios and 95% confidence intervals (95% CI) to determine whether serum IL-6 was associated with colorectal adenoma recurrence and flavonol intake and thus may serve as a risk indicator and as a response indicator to dietary flavonols. Serum IL-6 concentrations at baseline, year 1, and year 3 were measured in 872 participants from the intervention arm of the Polyp Prevention Trial, a 4-year trial that examined the effectiveness of a low-fat, high-fiber, high-fruit and vegetable diet on adenoma recurrence. Intake of flavonols, especially of isorhamnetin, kaempferol, and quercetin, was inversely associated with serum IL-6 concentrations (highest versus lowest flavonol intake quartile, 1.80 versus 2.20 pg/mL) and high-risk (OR, 0.51; 95% CI, 0.26-0.98) and advanced adenoma recurrence (OR, 0.17; 95% CI, 0.06-0.50). A decrease in IL-6 concentration during the trial was inversely associated with high-risk (OR, 0.44; 95% CI, 0.23-0.84) and advanced adenoma recurrence (OR, 0.47; 95% CI, 0.19-1.18). Individuals with above median flavonol intake and equal or below median IL-6 change after baseline had the lowest risk of recurrence of high-risk and advanced adenoma. Our results suggest that serum IL-6 may serve as a risk indicator and as a response indicator to dietary flavonols for colorectal cancer prevention. 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484173      PMCID: PMC2881177          DOI: 10.1158/1940-6207.CAPR-09-0161

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  44 in total

1.  Does nutritionist review of a self-administered food frequency questionnaire improve data quality?

Authors:  B J Caan; E Lanza; A Schatzkin; A O Coates; B K Brewer; M L Slattery; J R Marshall; A Bloch
Journal:  Public Health Nutr       Date:  1999-12       Impact factor: 4.022

2.  Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum.

Authors:  Thomas B Martins; Brian M Pasi; Christine M Litwin; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

3.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.

Authors:  A Schatzkin; E Lanza; D Corle; P Lance; F Iber; B Caan; M Shike; J Weissfeld; R Burt; M R Cooper; J W Kikendall; J Cahill
Journal:  N Engl J Med       Date:  2000-04-20       Impact factor: 91.245

4.  Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial.

Authors:  E Lanza; A Schatzkin; C Daston; D Corle; L Freedman; R Ballard-Barbash; B Caan; P Lance; J Marshall; F Iber; M Shike; J Weissfeld; M Slattery; E Paskett; D Mateski; P Albert
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

5.  Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma.

Authors:  Chikao Miki; Hitoshi Tonouchi; Reiko Wakuda; Tsuyoshi Hatada; Yasuhiro Inoue; Eiji Minato; Minàko Kobayashi; Masato Kusunoki
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

6.  Fruits, vegetables, and adenomatous polyps: the Minnesota Cancer Prevention Research Unit case-control study.

Authors:  Stephanie A Smith-Warner; Patricia J Elmer; Lisa Fosdick; Bryan Randall; Roberd M Bostick; Greg Grandits; Patricia Grambsch; Thomas A Louis; James R Wood; John D Potter
Journal:  Am J Epidemiol       Date:  2002-06-15       Impact factor: 4.897

7.  Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents.

Authors:  Marion M Chan; Dunne Fong; Kenneth J Soprano; William F Holmes; Harry Heverling
Journal:  J Cell Physiol       Date:  2003-01       Impact factor: 6.384

8.  Low energy reporting may increase in intervention participants enrolled in dietary intervention trials.

Authors:  Bette Caan; Rachel Ballard-Barbash; Martha L Slattery; Joan L Pinsky; Frank L Iber; Donna J Mateski; James R Marshall; Electra D Paskett; Moshe Shike; Joel L Weissfeld; Arthur Schatzkin; Elaine Lanza
Journal:  J Am Diet Assoc       Date:  2004-03

9.  Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.

Authors:  Aaron J Schetter; Giang Huong Nguyen; Elise D Bowman; Ewy A Mathé; Siu Tsan Yuen; Jason E Hawkes; Carlo M Croce; Suet Yi Leung; Curtis C Harris
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

Review 10.  The paradigm of IL-6: from basic science to medicine.

Authors:  Tetsuji Naka; Norihiro Nishimoto; Tadamitsu Kishimoto
Journal:  Arthritis Res       Date:  2002-05-09
View more
  23 in total

1.  Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

2.  Kaempferol attenuated cisplatin-induced cardiac injury via inhibiting STING/NF-κB-mediated inflammation.

Authors:  Yajun Qi; Yin Ying; Jie Zou; Qilu Fang; Xiaohong Yuan; Yingying Cao; Yunfang Cai; Shuang Fu
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

3.  Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Matthew R Young; Elaine Lanza; Arthur Schatzkin; Nancy H Colburn; Amanda J Cross
Journal:  Eur J Cancer Prev       Date:  2011-03       Impact factor: 2.497

Review 4.  A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

Authors:  Allen Y Chen; Yi Charlie Chen
Journal:  Food Chem       Date:  2012-12-28       Impact factor: 7.514

5.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

6.  Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma.

Authors:  Li Jiao; Liang Chen; Abeer Alsarraj; David Ramsey; Zhigang Duan; Hashem B El-Serag
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

Review 7.  Anticancer activity of flavonoids accompanied by redox state modulation and the potential for a chemotherapeutic strategy.

Authors:  Yongkyu Lee; Jehyung Lee; Changbaek Lim
Journal:  Food Sci Biotechnol       Date:  2021-03-20       Impact factor: 2.391

8.  Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.

Authors:  Curtis J Henry; Rebecca L Sedjo; Andrii Rozhok; Jennifer Salstrom; Dennis Ahnen; Theodore R Levin; Ralph D'Agostino; Steven Haffner; James DeGregori; Tim Byers
Journal:  BMC Cancer       Date:  2015-03-14       Impact factor: 4.430

9.  Role of life events in the presence of colon polyps among African Americans.

Authors:  Hassan Ashktorab; Hassan Hassanzadeh Namin; Teletia Taylor; Carla Williams; Hassan Brim; Thomas Mellman; Babak Shokrani; Cheryl L Holt; Adeyinka O Laiyemo; Mehdi Nouraie
Journal:  BMC Gastroenterol       Date:  2013-06-12       Impact factor: 3.067

Review 10.  New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers.

Authors:  Karen Brown; Alessandro Rufini
Journal:  Ecancermedicalscience       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.